Cancer Death Rates Fall 35% as FDA Approves 11 New Drugs, AACR Report Finds
The AACR Cancer Progress Report 2026 documents 11 new FDA drug approvals, a 35 percent decline in cancer deaths since ...
The AACR Cancer Progress Report 2026 documents 11 new FDA drug approvals, a 35 percent decline in cancer deaths since ...
A new review in Cancer Cell International details how cancer-associated fibroblasts remodel the colorectal tumor microenvironment and drive resistance to ...
A new Nature Cancer study reveals that the kinase GSK3β in colorectal tumor cells drives fumarate accumulation that epigenetically reprograms ...
New preclinical research shows that the plant compound coumarin activates natural killer cells, boosts their mitochondrial energy supply, and shrinks ...
A real-world study of 95 patients in Tokyo confirms that pembrolizumab combined with chemotherapy before and after surgery delivers event-free ...
A new review proposes co-designing oncolytic viruses and CAR-T or CAR-NK cells as a modular, self-amplifying therapeutic system to overcome ...
A new review maps how cancer-associated fibroblasts exclude immune cells from osteosarcoma tumors and outlines the therapeutic strategies that could ...
A new commentary synthesizes how gut microbial dysbiosis drives colorectal, gastric, and liver cancer and how microbiome-based diagnostics and therapies ...
Single-cell analysis of 56 glioblastoma tumors reveals that T-cell-rich cases harbor clonally expanded, LAG3-high CD8 T cells that may be ...
Researchers have developed engineered feeder cells derived from induced pluripotent stem cells that prolong the survival and boost the killing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine